197 results
6-K
EX-99.1
IPHA
Innate Pharma
28 May 24
Innate Pharma announces its participation in upcoming investor conferences
6:03am
contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use
6-K
EX-99.1
IPHA
Innate Pharma
24 May 24
Innate Pharma Highlights Abstracts Selected For ASCO 2024 Annual Meeting
6:35am
factors
This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform
6-K
EX-99.1
IPHA
Innate Pharma
23 May 24
Outcome of Innate Pharma’s 2024 Annual General Meeting
4:00pm
certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words
6-K
EX-99.1
IPHA
Innate Pharma
15 May 24
Innate Pharma Highlights Abstracts Selected For EHA 2024 Congress
6:01am
release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995
6-K
EX-99.1
IPHA
Innate Pharma
14 May 24
Innate Pharma Reports First Quarter 2024 Business Update And Financial Results
6:07am
of the Private Securities Litigation Reform Act of 1995. The use of certain words, including “believe,” “potential,” “expect” and “will” and similar
6-K
EX-99.1
n32a gj8e39fsr4
7 May 24
Innate Pharma announces conference call and webcast for Q1 2024 business update
6:03am
6-K
EX-99.1
cs6zfl pp4c6g867y
15 Apr 24
Innate Pharma Announces Advancement Of Sanofi-Developed Nk Cell Engager Sar443579 / Iph6101 Progressing To Phase 2 For Blood Cancer Patients
6:02am
6-K
EX-99.1
tmuwa
15 Apr 24
Current report (foreign)
6:00am
6-K
EX-99.1
4mq7gzpdhqu 8w079
10 Apr 24
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
6:51am
6-K
EX-99.1
0hn9gff o4qq
21 Mar 24
Innate Pharma reports Full Year 2023 Financial Results and Business Update
6:01am
6-K
EX-99.1
tl5k38
19 Mar 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:33am
6-K
EX-99.1
wtg2 bxou
14 Mar 24
Innate Pharma Announces Conference Call And Webcast For Full Year 2023 Financial Results
7:00am
6-K
EX-99.01
ayfahp y00tgi9
6 Mar 24
Current report (foreign)
6:00am
6-K
EX-99.01
9w4xzgprpaj
6 Mar 24
Current report (foreign)
6:00am
6-K
EX-99.1
hv4zdce3lgsv3xr
21 Feb 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:00am
6-K
EX-1.1
yfjl9 837o6io2147
6 Feb 24
Current report (foreign)
5:05pm
424B5
zb7ne kc3
6 Feb 24
Prospectus supplement for primary offering
5:00pm
6-K
EX-99.1
c4rb1ayw1anr 4e
12 Jan 24
Innate Pharma S.a. 6-K
6:00am